Cancer medicines
Rituximab
Rituximab
A CD20-targeting antibody used in selected B-cell lymphomas.
Sources checked · Introductory guide
On this page
How it works
It targets CD20 on B cells to help eliminate them.[3]
Where it is used
Used for CD20-positive non-Hodgkin lymphoma and certain chronic lymphocytic leukemias.[1]
Key safety points
Confirm hepatitis B screening before treatment. Report breathing difficulty, swelling or dizziness during infusion immediately.[2]
Questions for your care team
- How will hepatitis B reactivation and infusion reactions be managed?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Rituximab (opens in a new tab)
- MedlinePlus · Rituximab (opens in a new tab)
- NCI · Rituximab mechanism (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.